Endocrine Society Part of Coalition That Developed New Osteoporosis, Fracture Treatment Guidelines

  • Oct 2019

The Endocrine Society recently participated in a coalition of bone health experts, physicians, specialists, and patient advocacy groups to develop clinical care recommendations for the treatment of osteoporosis and resulting hip and spine fractures.

The Secondary Fracture Prevention: Consensus Recommendations from a Multistakeholder Coalition was published online in the peer-reviewed Journal of Bone and Mineral Research.

These recommendations outline the best course of clinical care for women and men, ages 65 years or older, with a hip or vertebral fracture, and emphasize that fracture patients should be managed in a multi-disciplinary clinical system to ensure appropriate evaluation and treatment for osteoporosis and risk of future fractures.

You may also like

  • Good Vibrations: A New FDA-Approved Device Could Offer a Solution for Osteopenia Treatment

    By Derek Bagley

    In a first for the treatment of osteopenia, the Osteoboost — a wearable device that delivers precise vibrations to the spine and hips — promises to offer a new form of therapy for clinicians treating postmenopausal women dealing with a loss of bone density.   At the beginning of 2024, the U.S. Food and Drug…

  • The Joy of Endocrinology: Joy Y. Wu, MD, PhD, Breaks the Glass and Bamboo Ceilings

    By Kelly Horvath

    As Endocrine News celebrates Asian American and Pacific Islander Heritage Month, we talk to Joy Y. Wu, MD, PhD, chief of the Division of Endocrinology at Stanford University about her personal and professional journey through the field of endocrinology as well as how her career path has been shaped by her mentors, colleagues, and especially…

Find more in